{"id":"https://openalex.org/W4416635053","doi":"https://doi.org/10.1183/13993003.congress-2025.pa1844","title":"Multiprotein predictor of short-term mortality in idiopathic pulmonary fibrosis (IPF)","display_name":"Multiprotein predictor of short-term mortality in idiopathic pulmonary fibrosis (IPF)","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416635053","doi":"https://doi.org/10.1183/13993003.congress-2025.pa1844"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa1844","doi":"https://doi.org/10.1183/13993003.congress-2025.pa1844","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa1844","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Idiopathic interstitial pneumonias","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043961879","display_name":"Jamie L. Todd","orcid":"https://orcid.org/0000-0003-4247-3693","observed_orcids":["https://orcid.org/0000-0003-4247-3693"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie L. Todd","raw_affiliation_strings":["1Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, United States","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050113875","display_name":"Hillary Mulder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hillary Mulder","raw_affiliation_strings":["2Duke Clinical Research Institute, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Duke Clinical Research Institute, Durham, NC, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033011383","display_name":"Megan Lee Neely","orcid":"https://orcid.org/0000-0002-0101-1081","observed_orcids":["https://orcid.org/0000-0002-0101-1081"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan L Neely","raw_affiliation_strings":["1Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, United States","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024144269","display_name":"Peitao Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peitao Wu","raw_affiliation_strings":["3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Conneticut, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Conneticut, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019397106","display_name":"John A. Belperio","orcid":"https://orcid.org/0000-0003-2379-5486","observed_orcids":["https://orcid.org/0000-0003-2379-5486"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A Belperio","raw_affiliation_strings":["4David Geffen School of Medicine at UCLA, Los Angeles, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4David Geffen School of Medicine at UCLA, Los Angeles, California, United States","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058325633","display_name":"Toby M. Maher","orcid":"https://orcid.org/0000-0001-7192-9149","observed_orcids":["https://orcid.org/0000-0001-7192-9149"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Toby M Maher","raw_affiliation_strings":["5Keck School of Medicine, University of Southern California, Los Angeles, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Keck School of Medicine, University of Southern California, Los Angeles, California, United States","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009091055","display_name":"Justin M. Oldham","orcid":"https://orcid.org/0000-0003-4957-8869","observed_orcids":["https://orcid.org/0000-0003-4957-8869"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin M Oldham","raw_affiliation_strings":["6Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085761603","display_name":"Scott M. Palmer","orcid":"https://orcid.org/0000-0002-1370-3771","observed_orcids":["https://orcid.org/0000-0002-1370-3771"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott M Palmer","raw_affiliation_strings":["1Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, United States","institution_ids":["https://openalex.org/I4210126298","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091760207","display_name":"Divya C. Patel","orcid":"https://orcid.org/0000-0001-5405-8409","observed_orcids":["https://orcid.org/0000-0001-5405-8409"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Divya C Patel","raw_affiliation_strings":["3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Conneticut, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Conneticut, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031173643","display_name":"Thomas Schlange","orcid":"https://orcid.org/0000-0002-2027-3976","observed_orcids":["https://orcid.org/0000-0002-2027-3976"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Schlange","raw_affiliation_strings":["7Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059230424","display_name":"Christian He\u00dflinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Hesslinger","raw_affiliation_strings":["7Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA1844","last_page":"PA1844"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":1.0},{"id":"https://openalex.org/keywords/short-term-mortality","display_name":"short-term mortality","score":0.925000011920929},{"id":"https://openalex.org/keywords/lung-transplantation","display_name":"lung transplantation","score":0.8040000200271606},{"id":"https://openalex.org/keywords/circulating-proteins","display_name":"circulating proteins","score":0.7860000133514404},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.7480000257492065},{"id":"https://openalex.org/keywords/prognostic-model","display_name":"prognostic model","score":0.8009999990463257},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.9340000152587891},{"id":"https://openalex.org/keywords/upar","display_name":"uPAR","score":0.7950000166893005},{"id":"https://openalex.org/keywords/surfactant-protein-d","display_name":"surfactant protein D","score":0.8920000195503235},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9440000057220459},{"id":"https://openalex.org/keywords/angiogenin","display_name":"angiogenin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/igfbp-2","display_name":"IGFBP-2","score":0.9940000176429749},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7950000166893005},{"id":"https://openalex.org/keywords/matrix-remodeling","display_name":"matrix remodeling","score":0.6349999904632568},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8240000009536743},{"id":"https://openalex.org/keywords/blood-coagulation","display_name":"coagulation","score":0.7070000171661377},{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":0.7329999804496765},{"id":"https://openalex.org/keywords/pirfenidone","display_name":"pirfenidone","score":1.0}],"concepts":[{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.9014000296592712},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.8305000066757202},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7886000275611877},{"id":"https://openalex.org/C16020263","wikidata":"https://www.wikidata.org/wiki/Q1778553","display_name":"DLCO","level":5,"score":0.7233999967575073},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6036999821662903},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5371999740600586},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.41839998960494995},{"id":"https://openalex.org/C55520419","wikidata":"https://www.wikidata.org/wiki/Q660995","display_name":"Vital capacity","level":5,"score":0.37439998984336853},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.3635999858379364},{"id":"https://openalex.org/C2781448352","wikidata":"https://www.wikidata.org/wiki/Q1637912","display_name":"Lung transplantation","level":3,"score":0.32420000433921814},{"id":"https://openalex.org/C2779832356","wikidata":"https://www.wikidata.org/wiki/Q2060696","display_name":"Pirfenidone","level":4,"score":0.3109000027179718},{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.28630000352859497},{"id":"https://openalex.org/C2780630273","wikidata":"https://www.wikidata.org/wiki/Q1988216","display_name":"Oxygen therapy","level":2,"score":0.2856000065803528},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.2851000130176544},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.2734000086784363},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.26249998807907104},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.26010000705718994},{"id":"https://openalex.org/C117220453","wikidata":"https://www.wikidata.org/wiki/Q5172842","display_name":"Correlation","level":2,"score":0.25099998712539673}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa1844","doi":"https://doi.org/10.1183/13993003.congress-2025.pa1844","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa1844","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Idiopathic interstitial pneumonias","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4207061571","https://openalex.org/W2007414618","https://openalex.org/W4387701231","https://openalex.org/W4404097316","https://openalex.org/W4225318507","https://openalex.org/W4404104187","https://openalex.org/W2529598770","https://openalex.org/W4387980030","https://openalex.org/W4416637052","https://openalex.org/W2130733764"],"abstract_inverted_index":{"Introduction:":[0],"Biomarkers":[1],"that":[2],"help":[3],"prognosticate":[4],"short-term":[5,22],"outcomes":[6],"in":[7,27,44,54,128,136,207,213,228,234],"patients":[8,28,264],"with":[9,29,68,105,202,265],"IPF":[10],"are":[11],"needed.":[12],"Aim:":[13],"Evaluate":[14],"the":[15,36,75,129,137,208,214,221,229,235,256],"extent":[16],"to":[17,242,258],"which":[18],"circulating":[19],"proteins":[20,43,189,239],"predict":[21],"death":[23,78,195],"or":[24,79,196],"lung":[25,80,197],"transplant":[26,81,198],"IPF.":[30,266],"Methods:":[31],"The":[32,124,145,238],"cohort,":[33],"drawn":[34],"from":[35],"IPF-PRO":[37],"Registry,":[38],"included":[39],"624":[40],"patients.":[41],"Sixty-seven":[42],"domains":[45],"of":[46,77,187,205,226],"inflammation,":[47],"matrix/epithelial":[48],"remodeling,":[49],"and":[50,121,132,139,165,173,181,190,211,232,250],"angiogenesis/coagulation":[51],"were":[52,62,111,116,169,245],"quantified":[53],"plasma":[55],"using":[56,142],"multiplexed":[57],"immunoassay":[58],"(Myriad":[59],"RBM).":[60],"Data":[61,115],"log2":[63],"transformed.":[64],"A":[65,185,217],"logistic":[66],"model":[67,125,218],"elastic":[69],"net":[70],"penalty":[71],"was":[72,126,147,156],"fit":[73],"for":[74,263],"outcome":[76,243],"at":[82,101,109,199],"18":[83,200],"months.":[84],"Proteins,":[85],"sex,":[86],"age,":[87],"smoking":[88],"status,":[89],"FVC":[90,162],"%":[91,94,163,167],"predicted,":[92,95],"DLCO":[93,166],"antifibrotic":[96],"drug":[97],"use,":[98],"oxygen":[99,103],"use":[100,104],"rest,":[102],"activity":[106],"(all":[107],"assessed":[108,135],"enrollment)":[110],"considered":[112],"as":[113],"predictors.":[114],"split":[117],"75/25":[118],"into":[119],"train":[120,130,138,209,230],"test":[122,140,215,236],"sets.":[123],"developed":[127],"set":[131,186,210,231],"its":[133],"performance":[134],"sets":[141],"C-index.":[143],"Results:":[144],"cohort":[146],"74.4%":[148],"male.":[149],"At":[150],"enrollment,":[151],"median":[152,161],"(Q1,":[153],"Q3)":[154],"age":[155],"70":[157],"(65,":[158],"75)":[159],"years;":[160],"predicted":[164,168],"69.1":[170],"(58.4,":[171],"79.4)":[172],"43.2":[174],"(33.4,":[175],"51.9),":[176],"respectively;":[177],"25.8%":[178],"took":[179,183],"nintedanib":[180],"23.6%":[182],"pirfenidone.":[184],"23":[188],"4":[191],"clinical":[192,222],"factors":[193,223],"discriminated":[194],"months":[201],"a":[203],"C-index":[204],"0.87":[206],"0.88":[212],"set.":[216,237],"including":[219],"only":[220],"had":[224],"C-indices":[225],"0.78":[227],"0.77":[233],"most":[240],"informative":[241],"discrimination":[244],"uPAR,":[246],"SP-D,":[247],"CRP,":[248],"angiogenin,":[249],"IGFBP2.":[251],"Conclusions:":[252],"Biomarker-inclusive":[253],"algorithms":[254],"have":[255],"potential":[257],"provide":[259],"meaningful":[260],"risk":[261],"stratification":[262]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2025-11-25T00:00:00"}